down arrow

Adline Chem Lab

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE276T01018
  • NSEID:
  • BSEID: 524604
INR
9.40
-0.36 (-3.69%)
BSENSE

Apr 11, 11:29 AM

BSE+NSE Vol: 200

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

200 (0.00%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

29.61%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

  • Poor long term growth as Net Sales has grown by an annual rate of -100.00% and Operating profit at -0.61% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2

Flat results in Sep 24

3

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 6 Cr (Micro Cap)

stock-summary
P/E

6.00

stock-summary
Industry P/E

24

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.84

stock-summary
Return on Equity

-10.50%

stock-summary
Price to Book

-3.33

Revenue and Profits (1 Year):
Net Sales:
(Quarterly Results - Sep 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-61.21%
0%
-61.21%
1 Year
0%
0%
0.0%
2 Years
74.07%
0%
74.07%
3 Years
36.63%
0%
36.63%
4 Years
84.31%
0%
84.31%
5 Years
79.05%
0%
79.05%

Adline Chem Lab for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-0.61%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
1.00
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
82.07%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
6
Industry P/E
24
Price to Book Value
-3.33
EV to EBIT
-7.15
EV to EBITDA
-7.15
EV to Capital Employed
-7.15
EV to Sales
NA
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Hemant Amrish Parikh (25.85%)

Highest Public shareholder

None

Individual Investors Holdings

60.15%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is -200.00% vs 99.27% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.07",
          "val2": "-0.03",
          "chgp": "-133.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.09",
          "val2": "-0.03",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 0.00% vs 0.00% in Sep 2023",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -100.00% vs 97.38% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.17",
          "val2": "-0.11",
          "chgp": "-54.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.07",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.22",
          "val2": "-0.11",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2023 is 0.00% vs -100.00% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2023 is 97.39% vs -455.26% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.11",
          "val2": "-0.71",
          "chgp": "84.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-4.35",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.11",
          "val2": "-4.22",
          "chgp": "97.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 0.00% vs -100.00% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 96.45% vs -687.50% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.18",
          "val2": "-5.14",
          "chgp": "96.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.15",
          "val2": "-4.23",
          "chgp": "96.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'24 - YoYstock-summary
Sep'24
Sep'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.07
-0.03
-133.33%
Interest
0.03
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.09
-0.03
-200.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Sep 2024 is -200.00% vs 99.27% in Sep 2023

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.17
-0.11
-54.55%
Interest
0.07
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.22
-0.11
-100.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

Growth in half year ended Sep 2024 is 0.00% vs 0.00% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -100.00% vs 97.38% in Sep 2023

Nine Monthly Results Snapshot (Standalone) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.11
-0.71
84.51%
Interest
0.00
0.00
Exceptional Items
0.00
-4.35
100.00%
Standalone Net Profit
-0.11
-4.22
97.39%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2023 is 0.00% vs -100.00% in Dec 2022

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2023 is 97.39% vs -455.26% in Dec 2022

Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.18
-5.14
96.50%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.15
-4.23
96.45%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 0.00% vs -100.00% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 96.45% vs -687.50% in Mar 2023

stock-summaryCompany CV
About Adline Chem Lab Ltd stock-summary
stock-summary
Adline Chem Lab Ltd
Micro Cap
Pharmaceuticals & Drugs
Adline Chem Lab Limited (Formerly known as Kamron Laboratories Limited) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari. The Company name was changed from `Kamron Laboratories Limited' to Adline Chem Lab Limited effective on October 13, 2021. The Company is engaged primarily in the business of marketing of Pharmaceutical and Nutraceuticals products. In May 1990, the Company started production at its site in Rakanpur, Gujarat.
Company Coordinates stock-summary
Company Details
904 9th Floor, Shapath-I Complex S G Highway Ahmedabad Gujarat : 382721
stock-summary
Tel: 91-02764-286549/286559
stock-summary
info@kamronlabs.com
Registrar Details
Kamron Laboratories Ltd., 737 Rakanpur Village, Sola Santej Road, Ta. Kalol (N. G.), Gandhinagar